Literature DB >> 23648637

ABO blood group: old dogma, new perspectives.

Massimo Franchini1, Giancarlo Maria Liumbruno.   

Abstract

Human blood group antigens are glycoproteins and glycolipids expressed on the surface of red blood cells and a variety of human tissues, including the epithelium, sensory neurons, platelets and the vascular endothelium. Accumulating evidence indicate that ABO blood type is implicated in the development of a number of human diseases, including cardiovascular and neoplastic disorders. In this review, beside its physiologic role in immunohematology and transfusion medicine, we summarize the current knowledge on the association between the ABO blood group and the risk of developing thrombotic events and cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23648637     DOI: 10.1515/cclm-2013-0168

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  28 in total

1.  ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey.

Authors:  Massimo Franchini; Chiara Rossi; Francesco Frattini; Silvia Crestani; Cinzia Sissa; Moreno Meschieri; Ivano Giacomini; Mario Luppi; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

2.  Do AB0 blood groups affect lower urinary tract symptoms?

Authors:  Erdal Benli; Abdullah Çırakoğlu; Ercan Öğreden; Yasemin Kaya; Ali Ayyıldız; Ahmet Yüce
Journal:  Turk J Urol       Date:  2018-11-19

3.  The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

Authors:  Oliver Engel; Armin Soave; Sven Peine; Luis A Kluth; Marianne Schmid; Shahrokh F Shariat; Roland Dahlem; Margit Fisch; Michael Rink
Journal:  World J Urol       Date:  2015-03-18       Impact factor: 4.226

Review 4.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

5.  The association between blood group and the risk of vascular disease in Quebec blood donors.

Authors:  Claudia Blais; Marc Germain; Gilles Delage; Yves Grégoire
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 6.  Hemostasis, cancer, and ABO blood group: the most recent evidence of association.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 7.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

8.  The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

Authors:  Enrico Capuzzo; Carlo Bonfanti; Francesco Frattini; Paolo Montorsi; Rosalia Turdo; Maria Grazia Previdi; Elisa Turrini; Massimo Franchini
Journal:  Ann Transl Med       Date:  2016-05

Review 9.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

10.  ABO blood groups and liver cancer: prospective results from an HBsAg cohort study.

Authors:  Ling-Ling Lu; Yong-Hui Zhang; Mei-Hua Yao; Jian-Hua Lu; Yong-Sheng Chen; Jun Xu; Jian Zhu; Hai-Zhen Chen; Jian-Guo Chen
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.